Patent Yard Sign in
Canadian application, no grantCanada

Direct detection of hepatitis c virus rna

CA 2077519 A1 · Owner: Vierling, John M. · Inventors: Hu, Ke-Qin; Vierling, John M.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Direct Detection of Hepatitis C Virus RNA Abstract, The methods and compositions of this invention provide a fast, accurate means for directly determining the presence and quantity of HCV in a sample and thus in, a patient, through hybridization to patient samples using a probe specific for HCV. They allow detection of both acute and chronic HCV infection. These methods and compositions also allow for the effective monitoring of therapeutic procedures for treating HCV infection.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed September 3, 1992. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 3, 2012.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 3, 2014.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledSeptember 3, 1992
GrantedNo grant recorded
Term endedSeptember 3, 2012
Patent numberCA 2077519 A1
Classification (IPC)C12Q1/70 +2 more

Timeline

Timeline From CIPO dates

1993199519971999200120032005200720092011Application filedSep 3, 1992Term endedSep 3, 2012

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.